VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ACA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ACAArcosa, Inc.
$145.29$7.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. ACA
  4. Financial Ratios

Arcosa, Inc. (ACA) Financial Ratios

Latest Ratios: P/E Ratio 34.3x · EV/EBITDA 15.0x · ROE 8.3%. (2016–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

ACA Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$7.1B$5.2B$4.7B$4.0B$2.6B$2.6B$2.7B$2.2B$1.4B——
Enterprise Value$8.4B$6.5B$6.3B$4.5B$3.1B$3.2B$2.8B$2.0B$1.4B——
P/E Ratio →34.2725.0850.6525.3510.7637.1125.2019.0417.86——
P/S Ratio2.471.811.841.741.181.261.381.240.93——
P/B Ratio2.711.991.941.731.211.311.411.200.80——
P/FCF40.6529.6815.1269.9972.6031.4614.987.8918.37——
P/OCF20.9115.279.4015.4215.1215.3810.256.0111.43——

P/E links to full P/E history page with 30-year chart

ACA EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—2.262.451.961.371.571.461.180.99——
EV / EBITDA14.9911.5716.0113.236.0912.7010.608.578.86——
EV / EBIT24.8219.1631.2920.218.8229.8718.9713.3215.02——
EV / FCF—37.1420.1378.7284.3639.2615.887.4919.54——

ACA Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin22.4%22.4%20.0%19.2%18.3%17.5%19.7%19.1%18.6%20.2%20.4%
Operating Margin11.8%11.8%7.7%7.9%15.6%5.3%7.8%8.8%6.5%9.0%11.8%
Net Profit Margin7.2%7.2%3.6%6.9%11.0%3.4%5.5%6.5%5.2%6.1%7.2%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE8.3%8.3%3.9%7.0%11.9%3.6%5.8%6.5%4.9%6.5%9.2%
ROA4.3%4.3%2.2%4.6%7.5%2.4%4.3%5.1%4.0%5.7%8.1%
ROIC6.4%6.4%4.3%5.0%10.1%3.5%6.1%6.6%4.5%7.2%11.3%
ROCE7.8%7.8%5.2%6.0%12.0%4.2%7.0%7.7%5.6%9.5%14.8%

ACA Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity0.580.580.720.260.270.360.130.070.110.00—
Debt / EBITDA2.702.704.461.771.172.810.960.551.140.00—
Net Debt / Equity—0.500.640.220.200.320.08-0.060.05-0.00-0.01
Net Debt / EBITDA2.322.323.991.470.852.520.60-0.460.53-0.03-0.05
Debt / FCF—7.455.018.7311.767.790.89-0.401.17-0.08-0.10
Interest Coverage3.133.132.837.9711.204.5714.0422.59106.56——

ACA Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio2.202.201.852.122.332.112.142.672.852.462.50
Quick Ratio1.351.351.151.181.471.221.251.671.771.050.93
Cash Ratio0.430.430.360.240.440.200.310.850.420.040.08
Asset Turnover—0.590.520.650.670.640.730.750.670.911.12
Inventory Turnover5.275.275.714.645.805.185.614.964.714.735.14
Days Sales Outstanding—52.8849.7456.4854.3955.7149.0742.0372.8341.2628.47

ACA Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield0.1%0.2%0.2%0.2%0.4%0.4%0.4%0.5%———
Payout Ratio4.8%4.8%10.4%6.2%4.0%14.1%9.2%8.7%———

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield2.9%4.0%2.0%3.9%9.3%2.7%4.0%5.3%5.6%——
FCF Yield2.5%3.4%6.6%1.4%1.4%3.2%6.7%12.7%5.4%——
Buyback Yield0.0%0.0%0.2%0.6%1.0%0.8%0.4%0.7%0.3%——
Total Shareholder Yield0.1%0.2%0.4%0.9%1.4%1.1%0.8%1.2%0.3%——
Shares Outstanding—$49M$49M$49M$49M$49M$49M$48M$49M$49M$49M

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Cyclical Margin Volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Premium Valuation Lacks Earnings Support

According to current market data, Arcosa trades at a 34.08x TTM P/E ratio, which appears disconnected from its recent operational performance and suggests investors are pricing in significant future growth that remains unverified by the company's current 2.39 PEG ratio and volatile earnings trajectory.

The current valuation premium relative to peers like CRH suggests the market is assigning a conglomerate multiple that may not be justified by the underlying cyclicality of the transportation and fabrication segments. Investors should monitor whether the company can sustain this multiple if the anticipated infrastructure-driven earnings growth fails to materialize in the coming quarters.

Capital Efficiency Remains Sub-Optimal

Based on reported financial figures, Arcosa's ROIC has struggled to gain traction, hovering near 0% in 2026Q1, which indicates that the company is currently failing to generate returns on invested capital that exceed its cost of capital, a trend that warrants further investigation by long-term shareholders.

The persistent decay in ROIC suggests that recent acquisitions and capital expenditures have not yet reached the necessary scale or efficiency to drive value creation. This performance gap compared to industry peers highlights the difficulty of integrating disparate business models while maintaining high returns on capital in a capital-intensive industrial environment.

Working Capital Cycles Impair Liquidity

As reported in quarterly filings, Arcosa's cash conversion cycle has expanded to 94 days in 2026Q1, reflecting a deterioration in working capital efficiency that suggests the company is increasingly reliant on inventory and receivables management to navigate its current operational challenges.

The lengthening of the CCC, driven by rising days sales outstanding and inventory levels, indicates potential friction in converting project-based revenue into actual cash inflows. This trend may suggest that the company is facing increased pressure from customers or supply chain bottlenecks, which could further strain liquidity if not addressed.

Backlog Misrepresents True Revenue Quality

Based on an analysis of Arcosa's reporting, the 'backlog' metric is frequently misapplied by market participants as a proxy for future profitability, when in reality it often obscures the impact of pass-through steel costs and the inherent margin volatility of long-term percentage-of-completion contracts.

Investors should prioritize Adjusted EBITDA and Free Cash Flow over backlog growth, as the latter can be inflated by inflationary pressures on raw materials rather than genuine volume expansion. Relying on backlog figures without adjusting for contract-specific margin risks may lead to an overestimation of the company's ability to convert future orders into sustainable earnings.

Download Financial Ratios Data

Includes 30+ ratios · 10 years · Updated daily

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

ACA — Frequently Asked Questions

Quick answers to the most common questions about buying ACA stock.

What is Arcosa, Inc.'s P/E ratio?

Arcosa, Inc.'s current P/E ratio is 34.3x. The historical average is 26.4x. This places it at the 75th percentile of its historical range.

What is Arcosa, Inc.'s EV/EBITDA?

Arcosa, Inc.'s current EV/EBITDA is 15.0x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 11.0x.

What is Arcosa, Inc.'s ROE?

Arcosa, Inc.'s return on equity (ROE) is 8.3%. The historical average is 6.8%.

Is ACA stock overvalued?

Based on historical data, Arcosa, Inc. is trading at a P/E of 34.3x. This is at the 75th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What is Arcosa, Inc.'s dividend yield?

Arcosa, Inc.'s current dividend yield is 0.14% with a payout ratio of 4.8%.

What are Arcosa, Inc.'s profit margins?

Arcosa, Inc. has 22.4% gross margin and 11.8% operating margin. Operating margin between 10-20% is typical for established companies.

How much debt does Arcosa, Inc. have?

Arcosa, Inc.'s Debt/EBITDA ratio is 2.7x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.